MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617029662 A) filed by Minghui Pharmaceutical Hangzhou Limited; and Minghui Pharmaceutical Shanghai Limited on March 12, 2026, for Anti-C-Met Nanobody And Use Thereof.
Inventors include Liu, Bo; Zhu, Liyuan; Cao, Guoqing; Shi, Junwei; Cao, Yuting; and Weng, Xialian.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: A nanobody specifically binding to c-MET or an antigen-binding fragment thereof, a composition containing the nanobody or the antigen-binding fragment thereof, and a nucleic acid molecule encoding the nanobody or the antigen-binding fragment thereof. Also provided is a use of the nanobody or the antigen-binding fragment thereof in the treatment and diagnosis of diseases.
Disclaimer: Curated by HT Syndication.
